首都医科大学学报 ›› 2025, Vol. 46 ›› Issue (3): 401-409.doi: 10.3969/j.issn.1006-7795.2025.03.002

• 肿瘤研究进展:从基础到临床 • 上一篇    下一篇

分子伴侣Cosmc或T-合酶缺失介导的异常O-糖基化调控结肠癌外泌体中微小RNA的表达

高天博,葛洋,安广宇,姚健楠,蒋玉良,刘贺书,闫锐*   

  1. 首都医科大学附属北京朝阳医院肿瘤科,北京 100020
  • 收稿日期:2025-01-17 出版日期:2025-06-21 发布日期:2025-06-20
  • 通讯作者: 闫锐 E-mail:yrui2019@126.com
  • 基金资助:
    首都医科大学自然类科研培育基金项目(PYZ21077)。

Abnormal O-glycosylation mediated by the deficiency of molecular chaperone Cosmc or T-synthase  regulates the expression of miRNAs in colorectal cancer exosomes

Gao Tianbo, Ge Yang, An Guangyu, Yao Jiannan, Jiang Yuliang, Liu Heshu, Yan Rui*   

  1. Department of Oncology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
  • Received:2025-01-17 Online:2025-06-21 Published:2025-06-20
  • Supported by:
    This study was supported by Natural Science Cultivation Fund of Capital Medical University (PYZ21077) .

摘要: 目的  探究Cosmc或T-合酶基因敲除引起的异常O-糖基化修饰对结肠癌外泌体中微小RNA表达模式的影响,以揭示O-糖基化在结肠癌发展中的分子机制,并识别潜在的生物标志物,为结肠癌的早期诊断和治疗提供新策略。方法  在人结肠癌细胞株HCT116中应用CRISPR/Cas-9基因编辑技术,分别靶向敲除Cosmc或T-合酶基因,以构建两种异常O-糖基化修饰的稳定转染细胞系。提取分离出肠癌细胞来源的外泌体,利用微小RNA(microRNAs, miRNAs)微阵列芯片,对比分析了其外泌体中miRNAs的表达差异。随后,在两组细胞来源的外泌体中筛选出表达量发生显著变化且变化趋势一致的miRNAs群体,采用传统荧光定量聚合酶链式反应(polymerase chain reaction,PCR)技术对这些miRNAs进行了独立验证。最后,通过癌症基因组图谱计划(The Cancer Genome Atlas Program,TCGA)数据库获取结直肠癌患者信息,利用R语言将表达上调的miRNA进行基因集富集分析(Gene Set Enrichment Analysis, GSEA),探索其显著相关的下游通路及表型。结果  无论是Cosmc还是T-合酶基因缺失均会导致结肠癌细胞中O-糖基化修饰发生异常,Tn抗原暴露,进而使得结肠癌细胞来源的外泌体中hsa-miR-125b-1-3p表达量下调(P<0.05),而hsa-miR-218-5p表达量上调(P<0.05),且与肿瘤细胞上皮-间质转化过程密切相关(P<0.05)。结论  由Cosmc或T-合酶基因缺失所介导的异常O-糖基化对结肠癌外泌体中相关miRNAs表达产生显著影响,进而可能影响结肠癌上皮-间质转化过程,从而促进肠癌远处转移。由此,基于肠癌外泌体的高稳定性及易检出性的天然优势,通过对其所携带miRNAs的表达量变化进行检测,可监测疾病进展和治疗效果,从而为结肠癌患者提供更为个性化的诊疗策略。

关键词: Cosmc, T-合酶, 结肠癌, O-糖基化, 外泌体, miRNAs

Abstract: Objective  To explore the effects of aberrant O-glycosylation modifications induced by the knockout of Cosmc or T-synthase genes on the expression profiles of miRNAs in exosomes derived from colorectal cancer cells and to reveal  the molecular mechanisms of O-glycosylation in the development of colorectal cancer and  identify potential biomarkers  for early diagnosis and treatment. Methods This research specifically targets the Cosmc or T-synthase genes in the human colorectal cancer cell line HCT116 to create stable cell lines exhibiting abnormal O-glycosylation with CRISPR/Cas-9 gene editing technology. Exosomes originating from these colorectal cancer cells were isolated and authenticated. A microarray chip equipped with primer sequences for 16 miRNAs closely associated with colorectal cancer was employed to assess the differential expression of miRNAs within these exosomes with fluorescent quantitative polymerase chain reaction (PCR). And then, a cohort of miRNAs that exhibited significant and consistent changes in expression levels across the exosomes from both cell lines was selected. These miRNAs were further validated independently with traditional fluorescent quantitative PCR. Subsequently, data from  The Cancer Genome Atlas Program(TCGA) database containing patient information on colorectal cancer was harnessed. Employing R programming language, Gene Set Enrichment Analysis (GSEA) was conducted on the upregulated miRNA to investigate the downstream pathways significantly impacted and the malignant biological behaviors they may influence. Results  The absence of either Cosmc or T-synthase genes results in the dysregulation of O-glycosylation in colorectal cancer cells, leading to the exposure of Tn antigens. This, in turn, affects the expression levels of specific miRNAs in exosomes derived from these cells. Specifically, the expression of hsa-miR-125b-1-3p was downregulated, while that of hsa-miR-218-5p was upregulated. Notably, hsa-miR-218-5p were found to be closely associated with the epithelial-mesenchymal transition (EMT) process in tumor cells, which is a key mechanism in cancer progression. Conclusion  It elucidates that the aberrant O-glycosylation mediated by the knockout of Cosmc or T-synthase genes significantly influences the expression of certain miRNAs in exosomes from colorectal cancer cells, potentially affect the EMT process in colorectal cancer and thereby promoting distant metastasis. Given the inherent stability and detectability advantages of colorectal cancer-derived exosomes, the altered expression levels of miRNAs within these exosomes may serve as indicators of the stated of abnormal O-glycosylation  in colorectal cancer. These findings suggest that exosomal miRNAs have potential as biomarkers for monitoring disease progression and therapeutic efficacy. Consequently, this could pave the way for more personalized diagnostic and treatment strategies tailored to individual colorectal cancer patients, enhancing the precision and effectiveness of clinical management.

Key words: Cosmc, T-synthase, colon cancer, O-glycosylation, exosome, miRNAs

中图分类号: